Role of Teduglutide in Managing Chronic Intestinal Failure
Session Date
Session Date:
November 1, 2022
Didactic
Didactic:
Palle Jeppesen, MD, PhD, Copenhagen, Denmark
At the end of this activity, participants will be able to
At the end of this activity, participants will be able to:
- Describe the physiology of GLP-2 in SBS-IF
- Describe results of the STEPS Trial for teduglutide use
- Discuss differential responses to GLP2 based on intestinal anatomy
info@liftecho.org
(212) 659-9300